קפיטליזציית שוק: Amgen Corporation (AMGN)

Amgen Inc. (AMGN) maintains its status as a biotech pioneer, countering intense pressure from biosimilars through colossal R&D expenditures. A team of leading chemists and biologists drives innovation, supported by top-tier laboratories and premium bonuses. This chart on the GURU.Markets platform reflects an asset value of 236.74, underscoring the scale of the business. Surplus cash flow ensures the confident repayment of debts.

The stability of Amgen Inc. (AMGN) is underpinned by a portfolio of indispensable biologics whose sales remain insulated from economic cycles. By analyzing the company's market capitalization chart, calculated as the product of the current share price and the total number of shares, an investor assesses the business's market value, where price resilience during crises confirms the asset's fundamental strength and determines its potential for future returns.